1. 20 Efficacy and safety of golimumab induction for moderate to severe ulcerative colitis in the united kingdom: results from the go-colitis. (5th April 2017) Authors: Probert, C; Gaya, D; Hamlin, PJ; Irving, P; Sebastian, S; Gillespie, G; Tate, H; Wheeler, C Journal: Gut Issue: Volume 66(2017)Supplement 1 Page Start: A8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 21 Patient-reported quality of life during golimumabinduction for moderate to severe ulcerative colitis in the united kingdom: results from the go-colitis study. (5th April 2017) Authors: Irving, P; Sebastian, S; Probert, C; Gaya, D; Hamlin, PJ; Gillespie, G; Tate, H; Wheeler, C Journal: Gut Issue: Volume 66(2017)Supplement 1 Page Start: A8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A biochemical mechanism for the role of allopurinol in TMPT inhibition. (13th March 2011) Authors: Blaker, P A; Arenas, M; Fairbanks, L; Irving, P; Marinaki, A M; Sanderson, J Journal: Gut Issue: Volume 60:(2011)Supplement 1 Page Start: A132 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. An audit of adherence to anti-tnf therapy in patients with inflammatory bowel disease. (13th March 2011) Authors: Duncan, J; Sastrillo, M; Baker, J; Younge, L; Anderson, S; Lindsay, J; Sanderson, J; Irving, P Journal: Gut Issue: Volume 60:(2011)Supplement 1 Page Start: A141 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. AODWE-005 Golimumab induction for moderate to severe ulcerative colitis: patient-reported outcomes of partial mayo score results from the go-colitis study. (17th June 2017) Authors: Sebastian, S; Probert, C; Gaya, D; Hamlin, PJ; Irving, P; Gillespie, G; Tate, H; Wheeler, C Journal: Gut Issue: Volume 66(2017)Supplement 2 Page Start: A122 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. DOP02 αEβ7 positive γδ T cells are associated with mucosal healing in Ulcerative Colitis and have a homeostatic immunophenotype. (27th May 2021) Authors: Dart, R; Zlatareva, I; Irving, P; Hayday, A Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S042 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. DOP06 Dynamic shifts in the balance of gut homing Treg and Th17 cells play a critical role in ulcerative colitis and may predict response to vedolizumab therapy. (25th January 2019) Authors: Hermangild Kottoor, S; Kassam, Z; Pavlidis, P; Alberts, E; Ibraheim, H; Constable, L; Digby-Bell, J; Warren, D; Odukwe, S; Samaan, M; Irving, P; Sanderson, J; Powell, N Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S030 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. DOP075 Colonic gamma delta t-cells respond innately to NKG2D ligands and are grossly dysregulated in active inflammatory bowel disease. (16th January 2018) Authors: Dart, R J; Vantourout, P; Laing, A; Digby-Bell, J; Powell, N; Irving, P; Hayday, A Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S081 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. DOP086 Low FODMAP diet improves functional-like gastrointestinal symptoms but reduces bifidobacteria and faecalibacterium prausnitzii in Quiescent inflammatory bowel disease: a randomised controlled trial and metagenomic analysis. (16th January 2018) Authors: Cox, S; Stagg, A; Fromentin, S; Ehrlich, D; McCarthy, N; Galleron, N; Levenez, F; Lomer, M; Lindsay, J; Irving, P; Whelan, K Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S087 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Effectiveness of temporary dose increase at recapturing response in patients on maintenance infliximab. (13th March 2011) Authors: Irving, P; Sastrillo, M; Duncan, J; Anderson, S; Sanderson, J Journal: Gut Issue: Volume 60:(2011)Supplement 1 Page Start: A204 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗